Learning Objectives:

1. Defining TNBC and the Prior Treatment Strategies 
2. Current Treatment Agents in Early-Stage TNBC
3. Future Therapeutics and Clinical Trials Presently For Early-Stage TNBC

Session date: 
10/24/2024 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ashley Hardeman, MD